- £40.77m
- £33.84m
- £46.09m
- 48
- 45
- 80
- 61
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11.4 | 13.6 | 15.6 | 21.1 | 46.1 |
Cost of Revenue | |||||
Gross Profit | 4.54 | 5.3 | 6.02 | 7.77 | 14.3 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 12.2 | 13.3 | 15 | 20 | 42.1 |
Operating Profit | -0.777 | 0.348 | 0.585 | 1.11 | 3.97 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.948 | 0.193 | 0.409 | 0.906 | 3.73 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.933 | 0.195 | 0.407 | 0.903 | 2.97 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.933 | 0.195 | 0.407 | 0.903 | 2.97 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.933 | 0.195 | 0.407 | 0.903 | 2.97 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.173 | 0.023 | 0.045 | 0.098 | 0.194 |